|
|
|||||||||
Clinical Investigations |
Departments of Radiology and Neuropsychiatry, Ehime University School of Medicine, Ehime; and Department of Medical Engineering, Division of Allied Health Sciences, Osaka University Medical School, Osaka, Japan
This study describes a method for quantifying cerebral blood flow (CBF) distribution in Alzheimers disease (AD) from SPECT images obtained with 99mTc-hexamethylpropyleneamine oxime (HMPAO) by 3-dimensional fractal analysis (3D-FA). Methods: HMPAO SPECT was performed on 68 patients with probable AD and 14 healthy control subjects. We delineated the CBF images using 4 cutoff levels (35%, 40%, 45%, and 50% of the maximal voxel radioactivity) and measured the total number of voxels in the areas surrounded by the contours obtained with each cutoff level. We calculated fractal dimensions from the relationship between the total number of voxels and the cutoff levels transformed into natural logarithms. Results: The fractal dimensions (mean ± SD) for patients with probable AD and healthy subjects were 0.74 ± 0.33 and 0.52 ± 0.09, respectively. A significant difference in the fractal dimension was found between groups (P = 0.001). Statistically significant correlations were obtained between the fractal dimension and the Mini-Mental State Examination score (r = -0.598; P < 0.0001) and between the fractal dimension and the AD Assessment Scale (r = 0.670; P < 0.0001). The fractal dimensions for subjects with clinical dementia rates (CDRs) of 0, 1, 2, and 3 were 0.52 ± 0.09, 0.63 ± 0.21, 0.77 ± 0.23 (P < 0.05 vs. the group with a CDR of 1), and 1.43 ± 0.49 (P < 0.0001 vs. the group with a CDR of 2), respectively. Conclusion: Quantification of CBF distribution on SPECT images in AD was possible using 3D-FA. The fractal dimension was well correlated with the cognitive impairment, as assessed in neuropsychologic tests. 3D-FA may be a useful method for objectively evaluating the progression of AD.
Key Words: fractal analysis cerebral blood flow Alzheimers disease SPECT
This article has been cited by other articles:
![]() |
J. A. Thie A Simple Interpretation of Fractal Analysis of Images J. Nucl. Med., April 1, 2004; 45(4): 724 - 724. [Full Text] [PDF] |
||||
![]() |
H.-W. Chung Blood Flow Heterogeneity Versus Cerebral Hypoperfusion Revealed by Fractal Analysis on 99mTc-HMPAO SPECT J. Nucl. Med., November 1, 2003; 44(11): 1874 - 1874. [Full Text] |
||||
![]() |
T. Yoshikawa, K. Murase, N. Oku, M. Imaizumi, M. Takasawa, P. Rishu, Y. Kimura, Y. Ikejiri, K. Kitagawa, M. Hori, et al. Heterogeneity of Cerebral Blood Flow in Alzheimer Disease and Vascular Dementia AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1341 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshikawa, K. Murase, N. Oku, K. Kitagawa, M. Imaizumi, M. Takasawa, T. Nishikawa, M. Matsumoto, J. Hatazawa, and M. Hori Statistical Image Analysis of Cerebral Blood Flow in Vascular Dementia with Small-Vessel Disease J. Nucl. Med., April 1, 2003; 44(4): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Chung and M. Nagao Fractal Analysis of Nuclear Medicine Images Again: Validity and Interpretation of Results from New Analysis Methods J. Nucl. Med., February 1, 2003; 44(2): 316 - 317. [Full Text] [PDF] |
||||
![]() |
J. T. Kuikka and M. Nagao Fractal Analysis of Cerebral Blood Flow Distribution in Alzheimer's Disease J. Nucl. Med., December 1, 2002; 43(12): 1727 - 1728. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |